Model
Edge
InMed Pharmaceuticals Inc.
INM
Filing Type
8-K
Filing Date
5/18/2026
Updated
5/19/26, 9:25 AM
Filing
8-K
Earnings Release
Exhibits
8-K
Material Contracts, Change in Company Ownership, Changes in Board, Management or Compensation, Reg. FD
EX-2.1
AGREEMENT AND PLAN OF MERGER AND REORGANIZATION, DATED AS OF MAY 19, 2026, BY AND AMONG INMED PHARMACEUTICALS INC., INDIGO MERGER SUB CORP., INDIGO MERGER SUB II, LLC AND MENTARI THERAPEUTICS, INC
EX-10.1
FORM OF SHAREHOLDER SUPPORT AGREEMENT
EX-10.2
FORM OF STOCKHOLDER SUPPORT AGREEMENT
EX-10.3
FORM OF LOCK-UP AGREEMENT
EX-10.4
FORM OF CVR AGREEMENT
EX-10.5
FORM OF MENTARI SECURITIES PURCHASE AGREEMENT
EX-99.1
Material Contracts, Change in Company Ownership, Changes in Board, Management or Compensation, Reg. FD
EX-99.2
Material Contracts, Change in Company Ownership, Changes in Board, Management or Compensation, Reg. FD
EX-99.3
Material Contracts, Change in Company Ownership, Changes in Board, Management or Compensation, Reg. FD
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic